CBL vs CBC: Parent and Breakdown Product
Leave cannabis in the light long enough and some of its CBC becomes something else. Ultraviolet light and heat close an extra ring in the molecule, and what comes out is CBL: the same formula, C₂₁H₃₀O₂, folded into a different shape. Neither one gets anyone high, and neither has been through a controlled human trial. Established
So the pair is a story about chemistry and shelf life, and only later, if ever, about effects. CBC is the parent compound. CBL is what CBC turns into as the material ages.
Every statement below is graded by the evidence behind it. Legal notes are general, dated and not legal advice; this page makes no therapeutic claim for either compound.
Side by side
| Attribute | CBL — cannabicyclol | CBC — cannabichromene |
|---|---|---|
| How it forms | CBL — cannabicyclolLight and heat close a ring in CBC; no enzyme makes it · Established | CBC — cannabichromeneCBCA synthase makes CBCA from CBGA, and heat converts that to CBC · Established |
| Molecular formula | CBL — cannabicyclolC₂₁H₃₀O₂ (CAS 21366-63-2) | CBC — cannabichromeneC₂₁H₃₀O₂ (CAS 20675-51-8) |
| Intoxicating? | CBL — cannabicyclolNo · Established | CBC — cannabichromeneNo · Established |
| Human evidence | CBL — cannabicyclolNo human study is known · No primary evidence | CBC — cannabichromeneNever tested in a controlled human trial · No primary evidence |
- How to read a cell
- An oxblood ring holds the direction: a bar: blocks; a chevron: activates; a chevron with a bar: activates, then desensitises; two bars: damps activation. A gold ring with a dot: recorded in a review, direction qualified by the source, no rung of its own. A dashed frame: no graded interaction in our registry.
- CB1 cannabinoid receptor
- CBL: no graded interaction in our registry. CBC: no graded interaction in our registry.
- CB2 cannabinoid receptor
- CBL: no graded interaction in our registry. CBC: no graded interaction in our registry.
- α2-adrenoceptor
- CBL: no graded interaction in our registry. CBC: no graded interaction in our registry.
- 5-HT1A serotonin receptor
- CBL: no graded interaction in our registry. CBC: no graded interaction in our registry.
- TRPV1 and TRPV2 ion channels
- CBL: no graded interaction in our registry. CBC: no graded interaction in our registry.
- TRPM8 ion channel
- CBL: no graded interaction in our registry. CBC: no graded interaction in our registry.
The settled facts
The chemistry is where the certainty lives, and there is more of it than the pair's obscurity would suggest.
- One ages into the other. Light or heat slowly converts CBC into CBL through a photochemical ring-closing reaction. Established
- Isomers. CBL and CBC share the formula C₂₁H₃₀O₂, with the atoms arranged differently. Established
- Neither gets anyone high. Both compounds are free of THC-like intoxication. Established
- The human record is blank. CBC has never been studied in a controlled human trial, and no human study of CBL is known. Both compounds are untested in people, which is a different verdict from tested and found wanting. No primary evidence
Common questions
How does CBL form from CBC?
Light turns one into the other. Ultraviolet exposure, helped along by heat and time, closes a ring in the CBC molecule and leaves CBL behind, which is why CBL accumulates as cannabis ages. Established
Are CBL and CBC the same molecule?
They are two different molecules built from the same atoms. Both are C₂₁H₃₀O₂, but CBL is CBC with an extra ring closed, and that rearrangement is enough to make a new compound. Established
Do CBL or CBC get you high?
No. Neither one is intoxicating. Established
Is there human evidence for CBL or CBC?
No. CBC has never been through a controlled human trial, and no human study of CBL is known. That is a gap in the research, not a negative result, and anything a label promises for either compound is running ahead of the research. Not medical advice. No primary evidence
Informational only — not our claims, and not advice. The statements on this page about potential effects, benefits, or uses reflect claims made by third parties (manufacturers, media, traditional use, or preliminary research) and are presented for educational and informational purposes only. CBG Atlas does not make, adopt, endorse, or affirm these claims, and does not represent them as fact. These statements have not been evaluated by the Food and Drug Administration (or any regulator) and are not intended to diagnose, treat, cure, or prevent any disease. Nothing here is medical, legal, or professional advice; cannabinoid effects, safety, and legal status vary by person, product, and jurisdiction and can change over time. Consult a qualified professional before making any health or purchasing decision. Where we can, we show how strong the evidence is and cite the source; where evidence is thin or absent, we say so. Peregrine Biopharma funds the platform and holds no editorial authority.
Sources
- De Petrocellis et al. (2011). Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. Br J Pharmacol. PMID 21175579.
Before you act on what you have read
Informational only, not medical advice. CBG Atlas is a scientific reference. Nothing here diagnoses, treats, cures or prevents any disease. Every claim on the page carries the grade of the evidence behind it, and the grade sets the words the claim may use. How we grade evidence.
Each grade rates the support for a claim across the literature. It does not rate any single study. An effect in cells may never show up in people. The grades cover the studies checked up to 9 August 2026. This page is for information and is not medical advice.
Cardiovascular note. CBG is a potent α2-adrenoceptor agonist in vitro, and α2 agonism can lower blood pressure. Anyone taking blood-pressure or other cardiovascular medication should consult a clinician before use. This is educational information, not medical advice.
Funding and independence. Peregrine Biopharma funds the platform and holds no editorial authority.
Report a safety event →Keep exploring
The compounds compared
More comparisons